Bank of America’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.31M Buy
3,214,293
+900,071
+39% +$1.79M ﹤0.01% 3586
2025
Q4
$5.67M Buy
2,314,222
+2,228,317
+2,594% +$9.68M ﹤0.01% 3286
2025
Q3
$576K Buy
85,905
+13,332
+18% +$87K ﹤0.01% 5702
2025
Q2
$427K Buy
72,573
+25,130
+53% +$164K ﹤0.01% 5798
2025
Q1
$398K Sell
47,443
-96,625
-67% -$868K ﹤0.01% 5780
2024
Q4
$1.07M Buy
144,068
+59,848
+71% +$400K ﹤0.01% 4972
2024
Q3
$488K Sell
84,220
-63,665
-43% -$409K ﹤0.01% 5496
2024
Q2
$983K Buy
147,885
+35,182
+31% +$284K ﹤0.01% 4917
2024
Q1
$1.47M Sell
112,703
-8,254
-7% -$110K ﹤0.01% 4658
2023
Q4
$1.54M Buy
120,957
+39,523
+49% +$399K ﹤0.01% 4627
2023
Q3
$1.07M Buy
81,434
+22,283
+38% +$408K ﹤0.01% 4774
2023
Q2
$1.51M Sell
59,151
-33,786
-36% -$872K ﹤0.01% 4455
2023
Q1
$2.34M Sell
92,937
-163,074
-64% -$3.83M ﹤0.01% 4217
2022
Q4
$5.89M Buy
256,011
+188,211
+278% +$4.33M ﹤0.01% 3243
2022
Q3
$1.5M Buy
67,800
+8,797
+15% +$170K ﹤0.01% 4544
2022
Q2
$846K Sell
59,003
-1,715
-3% -$28.9K ﹤0.01% 5051
2022
Q1
$1.15M Buy
60,718
+44,204
+268% +$859K ﹤0.01% 5100
2021
Q4
$308K Buy
16,514
+15,536
+1,589% +$321K ﹤0.01% 6224
2021
Q3
$26K Buy
978
+784
+404% +$21.6K ﹤0.01% 7316
2021
Q2
$6K Buy
+194
New +$6.17K ﹤0.01% 7405

Other funds holding TMCI

Bank of America's TMCI Position: Q1 2026 in Review

Bank of America increased its Treace Medical Concepts (TMCI) stake by 39% in Q1 2026, buying an estimated $1.79M and bringing the position to 3,214,293 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

Bank of America first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.89M in Q4 2022. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Bank of America held 3,214,293 shares of Treace Medical Concepts worth $4.31M as of Q1 2026.
  • Bank of America bought 900,071 Treace Medical Concepts shares in Q1 2026, an estimated $1.79M.
  • Treace Medical Concepts made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3586 holding.
  • Bank of America first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Treace Medical Concepts position peaked at $5.89M in Q4 2022.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.